| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc. | Sr VP & Chief Medical Officer | Employee Stock Option (Right to Buy) | 35,000 | 05 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APTOF | Aptose Biosciences Inc. | 05 Feb 2024 | 1 | $0 | 4 | Sr VP & Chief Medical Officer | 07 Feb 2024, 17:45 |
| APTOF | Aptose Biosciences Inc. | 19 Jan 2023 | 2 | $0 | 4 | Sr. VP, Chief Medical Officer | 23 Jan 2023, 18:50 |
| APTOF | Aptose Biosciences Inc. | 18 Jan 2022 | 1 | $0 | 4 | Sr. VP, Chief Medical Officer | 20 Jan 2022, 16:16 |
| APTOF | Aptose Biosciences Inc. | 19 Nov 2021 | 1 | +$25,600 | 4 | Sr. VP, Chief Medical Officer | 19 Nov 2021, 19:36 |
| APTOF | Aptose Biosciences Inc. | 19 Aug 2021 | 2 | $0 | 4 | Sr. VP, Chief Medical Officer | 23 Aug 2021, 16:53 |